These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6675189)

  • 41. Immunohistochemical study of delta antigen in an American metropolitan population.
    Thung SN; Gerber MA
    Liver; 1983 Dec; 3(6):392-7. PubMed ID: 6366423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and clinical impact of hepatitis D virus (delta) infection.
    Jacobson IM; Dienstag JL; Werner BG; Brettler DB; Levine PH; Mushahwar IK
    Hepatology; 1985; 5(2):188-91. PubMed ID: 3979950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and histological features of delta infection in chronic hepatitis B virus carriers.
    Lok AS; Lindsay I; Scheuer PJ; Thomas HC
    J Clin Pathol; 1985 May; 38(5):530-3. PubMed ID: 3998187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delta agent and hepatitis B.
    Redeker AG
    Ann Intern Med; 1983 Apr; 98(4):542-3. PubMed ID: 6838075
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-lasting abatement of HBsAg synthesis induced by acute delta infection.
    Frommel D; Allain JP; Courouce AM; Derose S; Trepo D; Crivelli O; Rizzetto M
    Lancet; 1983 Mar; 1(8325):656-7. PubMed ID: 6131340
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of delta infection in drug addicts in Valencia, Spain.
    Rodrigo JM; Serra MA; Gimeno V; Olmo JA; Aparisi L; Escudero A; Wassel AH; Bixquert M
    Prog Clin Biol Res; 1987; 234():407-8. PubMed ID: 3628399
    [No Abstract]   [Full Text] [Related]  

  • 48. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Viral hepatitis in drug-addicts: anatomo-clinical correlations].
    Camarri E; Corsini P; Marchettini G; Almi P; de' Santi MM; del Vecchio MT; Leoncini L; Cintorino M; Luzi P; Tosi P
    Clin Ter; 1984 Aug; 110(4):311-26. PubMed ID: 6237867
    [No Abstract]   [Full Text] [Related]  

  • 50. [The delta agent and its value in hepatic pathology in children].
    Maggiore G
    Arch Fr Pediatr; 1986 Jan; 43(1):55-9. PubMed ID: 3518650
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.
    Stimmel B; Vernace S; Schaffner F
    JAMA; 1975 Dec; 234(11):1135-8. PubMed ID: 810605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
    Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
    Naoumov NV; Gueorgiev A; Ognyanov M; Maleev A
    Hepatogastroenterology; 1986 Apr; 33(2):49-51. PubMed ID: 3721387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
    Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
    Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
    [No Abstract]   [Full Text] [Related]  

  • 57. Delta virus infections in and around Chandigarh, northern India: evidence for endemicity.
    Pal SR; Prasad SR
    Trop Geogr Med; 1987 Apr; 39(2):123-5. PubMed ID: 3629703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody to hepatitis D virus (delta agent) in selected Manitoba residents, 1974-1986.
    Hannan C; Sekla L; Schacter B; Stackiw W
    Clin Invest Med; 1988 Jun; 11(3):209-12. PubMed ID: 3135966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
    Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
    Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes.
    Caredda F; De Franchis R; D'Arminio Monforte A; Vecchi M; Antoniozzi F; Rossi E; Primignani M; Moroni M
    Boll Ist Sieroter Milan; 1984; 63(6):496-8. PubMed ID: 6534395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.